Hsbc Holdings PLC Amneal Pharmaceuticals, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 46,304 shares of AMRX stock, worth $363,486. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,304

Previous 43,841 5.62%

Holding current value

$363,486

Previous $278,000 38.49%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.42 - $8.83 $15,812 - $21,748	2,463 Added 5.62%	46,304 $385,000
Q2 2024 Aug 12, 2024	SELL	$5.36 - $7.11 $1.33 Million - $1.76 Million	-247,568 Reduced 84.96%	43,841 $278,000
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $1.53 Million - $1.85 Million	291,409 New	291,409 $1.77 Million
Q3 2023 Nov 13, 2023	BUY	$2.76 - $4.59 $31,555 - $52,477	11,433 New	11,433 $48,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $4,970 - $6,618	2,536 Added 6.43%	41,979 $83,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $53,449 - $95,785	-26,460 Reduced 40.15%	39,443 $82,000
Q2 2022 Aug 11, 2022	BUY	$3.01 - $4.46 $29,302 - $43,418	9,735 Added 17.33%	65,903 $214,000
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $237 - $298	61 Added 0.11%	56,168 $236,000
Q4 2021 Feb 11, 2022	BUY	$3.95 - $5.85 $221,622 - $328,225	56,107 New	56,107 $268,000
Q3 2020 Nov 12, 2020	SELL	$3.54 - $5.27 $66,378 - $98,817	-18,751 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $5,160 - $9,817	-1,798 Reduced 8.75%	18,751 $89,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $128,980 - $280,505	-52,431 Reduced 71.84%	20,549 $69,000
Q4 2019 Feb 14, 2020	SELL	$2.65 - $5.56 $126,654 - $265,734	-47,794 Reduced 39.57%	72,980 $351,000
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $276,572 - $857,495	120,774 New	120,774 $350,000
Q2 2019 Aug 13, 2019	SELL	$6.44 - $14.29 $201,932 - $448,077	-31,356 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.87 - $14.84 $64,323 - $80,417	5,419 Added 20.89%	31,356 $445,000
Q4 2018 Feb 13, 2019	SELL	$13.09 - $21.49 $35,028 - $57,507	-2,676 Reduced 9.35%	25,937 $350,000
Q3 2018 Nov 13, 2018	BUY	$16.4 - $24.27 $60,778 - $89,944	3,706 Added 14.88%	28,613 $635,000
Q2 2018 Aug 10, 2018	BUY	$13.95 - $20.2 $347,452 - $503,121	24,907 New	24,907 $409,000

Others Institutions Holding AMRX

# of Institutions

184

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Amneal Pharmaceuticals, Inc. Transaction History